Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
01 1Interquim S. A.
02 1Active Pharma Inc.
03 1Alembic Pharmaceuticals Limited
04 1Aurobindo Pharma Limited
05 1DONGBANG FUTURE TECH & LIFE CO. , LTD.
06 1Daito Co., Ltd.
07 1Hetero Labs Limited
08 2JUBILANT PHARMOVA LIMITED
09 1KOLON LIFE SCIENCE, INC.
10 1Kyongbo Pharmaceutical Co. , Ltd.
11 1Organic Synthesis Chemicals Co., Ltd.
12 1Polaris AI Pharma Corp.
13 1Sanyo Chemical Research Institute Co., Ltd.
14 1Sumitomo Chemical Co., Ltd.
15 1Tianish Laboratories Private Limited
16 2Zhejiang Tianyu Pharmaceutical Co. , Ltd.
17 1Zhuhai Rundu Pharmaceutical Co. , Ltd.
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
Registration Number : 227MF10298
Registrant's Address : Joan Buscala, 10 E-08173 Sant Cugat del Valles, Barcelona, Spain
Initial Date of Registration : 2015-12-28
Latest Date of Registration : 2020-05-12
A Olmesartan Medoxomil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olmesartan Medoxomil, including repackagers and relabelers. The FDA regulates Olmesartan Medoxomil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olmesartan Medoxomil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Olmesartan Medoxomil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Olmesartan Medoxomil supplier is an individual or a company that provides Olmesartan Medoxomil active pharmaceutical ingredient (API) or Olmesartan Medoxomil finished formulations upon request. The Olmesartan Medoxomil suppliers may include Olmesartan Medoxomil API manufacturers, exporters, distributors and traders.
click here to find a list of Olmesartan Medoxomil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Olmesartan Medoxomil Drug Master File in Japan (Olmesartan Medoxomil JDMF) empowers Olmesartan Medoxomil API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Olmesartan Medoxomil JDMF during the approval evaluation for pharmaceutical products. At the time of Olmesartan Medoxomil JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Olmesartan Medoxomil suppliers with JDMF on PharmaCompass.
We have 16 companies offering Olmesartan Medoxomil
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
